SCHEMBL14254298

SCHEMBL14254298

CCOC(=O)c1cccc(Nc2cc(-c3ccc(OC)c(N)c3)ccn2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.54
▸ TP53 P04637 2/20 0.54
▸ LMNA P02545 2/20 0.54
▸ THRB P10828 1/20 0.54
▸ CDC25B P30305 4/20 0.53
▸ SYK P43405 1/20 0.50
▸ EGFR P00533 1/20 0.49
▸ ERBB3 P21860 1/20 0.49
▸ ROCK1 Q13464 1/20 0.49
▸ NPC1 O15118 3/20 0.48
▸ RAB9A P51151 3/20 0.48
▸ SMN1; SMN2 Q16637 3/20 0.48
▸ KDM4E B2RXH2 2/20 0.48
▸ BRAF P15056 2/20 0.47
▸ TSHR P16473 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ MEN1 O00255 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14253952 0.84 SYK (0.59) MAPTTP53LMNATHRBCDC25B
SCHEMBL31240287 0.80 TP53 (0.52) MAPTTP53LMNATHRBCDC25B
SCHEMBL1519024 0.79 MAPT (0.62) MAPTTP53LMNATHRBSYK
SCHEMBL14254297 0.79 ROCK1 (0.57) MAPTSYKEGFRERBB3ROCK1
SCHEMBL14254299 0.79 MAPK10 (0.52) SYKEGFRERBB3ROCK1MAPK8
SCHEMBL14254293 0.79 MAPK10 (0.57) EGFRROCK1NPC1RAB9AMEN1
SCHEMBL14254294 0.78 MAPK10 (0.48) MAPTTP53EGFRROCK1BRAF
SCHEMBL14254295 0.78 EGFR (0.50) MAPTTP53LMNAEGFRERBB3
SCHEMBL31240717 0.78 TP53 (0.51) MAPTTP53LMNATHRBCDC25B
SCHEMBL31240741 0.77 MAPT (0.61) MAPTTP53LMNATHRBCDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7348335-B2 Compositions useful as inhibitors of JAK and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-03-25 — — US disclosed
US-7348335-B2 Compositions useful as inhibitors of JAK and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-03-25 — — US disclosed
Send feedback